mdlinx mdlinx

Oncology News & Articles

Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.

On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx
New! >> Find out who is the Smartest Doc in Oncology!

Articles

Latest (177) Full Text Articles (6313) Focus on Hematology
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

141 Impact of international variation of prostate cancer on a predictive nomogram for biochemical recurrence in clinically localised prostate cancer World Journal of Urology, June 19, 2013    Clinical Article

142 Diabetes-free survival in patients who underwent islet autotransplantation after 50% to 60% distal partial pancreatectomy for benign pancreatic tumors Transplantation, June 19, 2013    Clinical Article

143 A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia Transfusion, June 19, 2013

144 The epidemiology of high-risk prostate cancer Current Opinion in Urology, June 19, 2013    Clinical Article

145 LEP gene variant is associated with prostate cancer but not with colorectal cancer Tumor Biology, June 19, 2013    Evidence Based Medicine    Review Article

146 Prognostic value of cyclin E expression in breast cancer: a meta-analysis Tumor Biology, June 19, 2013    Evidence Based Medicine    Review Article

147 Serum neuron-specific enolase levels were associated with the prognosis of small cell lung cancer: a meta-analysis Tumor Biology, June 19, 2013    Evidence Based Medicine    Review Article

148 The polymorphisms in the MGMT gene and the risk of cancer: a meta-analysis Tumor Biology, June 19, 2013    Evidence Based Medicine    Review Article

149 MicroRNA-200a/b influenced the therapeutic effects of curcumin in hepatocellular carcinoma (HCC) cells Tumor Biology, June 19, 2013    Clinical Article

150 Paraneoplastic hormones: parathyroid hormone-related protein (PTHrP) and erythropoietin (EPO) are related to vascular endothelial growth factor (VEGF) expression in clear cell renal cell carcinoma Tumor Biology, June 19, 2013    Clinical Article

151 Inhibition of mTOR and HIF pathways diminishes chondro-osteogenesis and cell proliferation in chondroblastoma Tumor Biology, June 19, 2013    Clinical Article

152 Association between MTHFR 677C>T polymorphism and risk of gliomas: evidence from a meta-analysis Tumor Biology, June 19, 2013    Evidence Based Medicine    Review Article

153 Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population Tumor Biology, June 19, 2013    Clinical Article

154 Effects of CXCR4 gene silencing by lentivirus shRNA on proliferation of the EC9706 human esophageal carcinoma cell line Tumor Biology, June 19, 2013    Clinical Article

155 Predictive factors influencing facial nerve outcomes in surgery for small-sized vestibular schwannoma Acta Oto-Laryngologica , June 19, 2013    Review Article

156 Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention against head and neck cancer-containing HPV16 cell lines Acta Oto-Laryngologica , June 19, 2013    Review Article

157 A case report of rapid spontaneous redistribution of acute supratentorial subdural hematoma to the entire spinal subdural space presenting as a Pourfour du Petit Syndrome and review of the literature Clinical Neurology and Neurosurgery, June 19, 2013

158 Cost-effectiveness of recombinant activated factor VII vs. plasma-derived activated prothrombin complex concentrate in the treatment of mild-to-moderate bleeding episodes in patients with severe haemophilia A and inhibitors in Spain Haemophilia, June 19, 2013    Clinical Article

159 What have we gained by performing robotic rectal resection? evaluation of 64 consecutive patients who underwent laparoscopic or robotic low anterior resection for rectal adenocarcinoma Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, June 19, 2013    Clinical Article

160 Androgen-deprivation therapy versus radical prostatectomy as monotherapy among clinically localized prostate cancer patients Full Text OncoTargets and Therapy, June 19, 2013    Clinical Article

50 available pages First Previous 8 9 10 11 12 13 14 15 16 17 Next Last

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Other Topics in Oncology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close